AQUA BIO TECHNOLOGY ASA: NØKKELINFORMASJON VEDRØRENDE ETTERFØLGENDE EMISJON

Written by Customer Service on . Posted in Public Companies.

Det vises til melding fra Aqua Bio Technology ASA den 17. august 2020 vedrørende, blant annet, to rettede emisjoner med totalt bruttoproveny på NOK 12,6 millioner samt en planlagt etterfølgende emisjon (den “Etterfølgende Emisjonen“).Det formelle vedtaket (herunder endelig antall aksjer som vil tilbys) tilknyttet den Etterfølgende Emisjonen vil vedtas av styret på et senere tidspunkt, og nærmere informasjon vil gis.Denne meldingen offentliggjøres i henhold til kravene i Løpende Forpliktelser.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.